J
JAZZ
Jazz Pharmaceuticals Plc
137.64
1.34+0.98%Pre Market: 138.00 +0.36 +0.26%05:28 11/03 EST
OPEN/PREV CLOSE136.78/136.30
TODAY RANGE135.64-138.31
VOL5
MARKET CAP8.35B
52 WEEK RANGE95.49-148.06
AVG VOL (3M)753.54K
% TURNOVER0.86%
TURNOVER0
P/E (TTM)-20.4508
% RANGE1.95%
EPS(TTM)-6.7303
P/E(FORWARD)-17.5561
P/B2.252
BVPS61.12
DIVIDEND--
P/S2.051
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.09B
SHARES OUTSTANDING60.66M
NEXT EARNINGS11/04-11/10
FREE FLOAT58.79M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·16h ago
Aristotle Global Equity Advisory Q3 2025 Contributors And Detractors
Simply Wall St·1d ago
Are Jazz Pharmaceuticals Shares Still Attractive After a 25% Climb and New Pipeline Developments?
Simply Wall St·2d ago
How Investors May Respond To Jazz Pharmaceuticals (JAZZ) Settling Global LUMRYZ Patent Dispute with Avadel
TipRanks·5d ago
Jazz Pharmaceuticals Appoints Dr. Ted Love to Board
Dow Jones·6d ago
Jazz Pharmaceuticals Is Maintained at Overweight by JP Morgan
Seeking Alpha·10/26 13:45
3 Biopharma Names I Am Buying After Avadel's Buyout
Simply Wall St·10/25 00:33
Does the Avadel Settlement Redefine the Oxybate Opportunity for Jazz Pharmaceuticals (JAZZ)?
TipRanks·10/24 13:25
Morgan Stanley Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
Same Industry
Name/Symbol
Change%
Price